Interactions of cryptolepine and neocryptolepine with unsual DNA structures

Biochimie

Volumn 85, Issue 5, 2003, Pages 535-547

  Guittat, Lionel ^a   Alberti, Patrizia ^a   Rosu, Frédéric ^b   Van Miert, Sabine ^c   Thetiot, Emilie ^a   Pieters, Luc ^c   Gabelica, Valérie ^b   De Pauw, Edwin ^b   Ottaviani, Alexandre ^a   Riou, Jean François ^d   Mergny, Jean Louis ^a  

^a MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Cryptolepine; Quadruplex; Telomerase; Telomere; Triplex

Indexed keywords

CRYPTOLEPINE; CRYPTOLEPINE DERIVATIVE; DNA; NEOCRYPTOLEPINE; SINGLE STRANDED DNA; TELOMERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; AT RICH SEQUENCE; BINDING AFFINITY; BINDING COMPETITION; CONTROLLED STUDY; DNA STRAND; DNA STRUCTURE; DRUG DNA INTERACTION; DRUG EFFECT; DRUG SELECTIVITY; EQUILIBRIUM DIALYSIS; GC RICH SEQUENCE; MASS SPECTROMETRY; NUCLEIC ACID STRUCTURE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TRIPLE HELIX;

CRYPTOLEPIS; CRYPTOLEPIS SANGUINOLENTA;

EID: 0037518359     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(03)00035-X     Document Type: Article

References (55)

1. E.D. Clinquart, On the chemical composition of Cryptolepis triangularis, plant from the (Belgian) Congo, Bull. Acad. R. Med. 9 (1929) 627-635.
2. E. Delvaux, On cryptolepine, J. Pharm. Belg. 13 (1931) 955-959.
3. D. Dwuma-Badu, J.S. Ayim, N.I. Fiagbe, J.E. Knapp, P.L. Schiff Jr, D.J. Slatkin, Constituents of west African medicinal plants XX: Quindoline from Cryptolepis sanguinolenta, J. Pharm. Sci. 67 (1978) 433-434.
4. G. Boye, O. Ampofo, Proceedings of the First International Seminar on Cryptolepine, University of Kumasi, Ghana, 1983.
5. K. Bonjean, M.C. De Pauw-Gillet, M.P. Defresne, P. Colson, C. Houssier, L. Dassonneville, C. Bailly, R. Greimers, C. Wright, J. Quetin-Leclercq, M. Tits, L. Angenot, The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells, Biochemistry 37 (1998) 5136-5146.
6. C.W. Wright, J. Addae-Kyereme, A.G. Breen, J.E. Brown, M.F. Cox, S.L. Croft, Y. Gokcek, H. Kendrick, R.M. Phillips, P.L. Pollet, Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents, J. Med. Chem. 44 (2001) 3187-3194.
7. C. Bailly, W. Laine, B. Baldeyrou, M.C. De Pauw-Gillet, P. Colson, C. Houssier, K. Cimanga, S. Van Miert, A.J. Vlietinck, L. Pieters, DNA intercalation, topoisomerase II inhibition and cytotoxic activity of the plant alkaloid neocryptolepine, Anticancer Drug Des. 15 (2000) 191-201.
8. L. Dassonneville, A. Lansiaux, A. Wattelet, N. Wattez, C. Mahieu, S. Van Miert, L. Pieters, C. Bailly, Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: Relation to drug-induced apoptosis, Eur. J. Pharmacol. 409 (2000) 9-18.
9. J.N. Lisgarten, M. Coll, J. Portugal, C.W. Wright, J. Aymami, The antimalarial and cytotoxic drug cryptolepine intercalates into DNA at cytosine-cytosine sites, Nat. Struct. Biol. 9 (2002) 57-60.
10. T. Le Doan, L. Perrouault, D. Praseuth, N. Habhoub, J.L. Decout, N.T. Thuong, J. Lhomme, C. Hélène, Sequence specific recognition, photocrosslinking and cleavage of the DNA double helix by an oligo a thymidylate covalently linked to an azidoproflavine derivative, Nucleic Acids Res. 15 (1987) 7749-7760.
11. H.E. Moser, P.B. Dervan, Sequence specific cleavage of double helical DNA by triple helix formation, Science 238 (1987) 645-650.
12. J.C. François, T. Saison-Behmoaras, N.T. Thuong, C. Hélène, Inhibition of restriction endonuclease cleavage via triple helix formation by homopyrimidine oligonucleotides, Biochemistry 28 (1989) 9617-9619.
13. C. Giovannangeli, S. Diviacco, V. Labrousse, S. Gryaznov, P. Charneau, C. Hélène, Accessibility of nuclear DNA to triplex-forming oligonucleotides: The integrated HIV-1 provirus as a target, Proc. Natl. Acad. Sci. USA 94 (1997) 79-84.
14. M. Mills, P. Arimondo, L. Lacroix, T. Garestier, C. Hélène, H.H. Klump, J.L. Mergny, Energetics of strand displacement reactions in triple helices: A spectroscopic study, J. Mol. Biol. 291 (1999) 1035-1054.
15. J.L. Mergny, G. Duval-Valentin, C.H. Nguyen, L. Perrouault, B. Faucon, M. Rougée, T. Montenay-Garestier, E. Bisagni, C. Hélène, Triple helix specific ligands, Science 256 (1992) 1691-1694.
16. J.S. Sun, J.C. François, T. Montenay-Garestier, T. Saison-Behmoaras, V. Roig, M. Chassignol, N.T. Thuong, C. Hélène, Sequence-specific intercalating agents. Intercalation at specific sequences on duplex DNA via major-groove recognition by oligonucleotide intercalator conjugates, Proc. Natl. Acad. Sci. USA 86 (1989) 9198-9202.
17. S. Neidle, G. Parkinson, Telomere maintenance as a target for anticancer drug discovery, Nat. Rev. Drug Des. 1 (2002) 383-393.
18. J.L. Mergny, J.F. Riou, P. Mailliet, M.P. Teulade-Fichou, E. Gilson, Natural and pharmacological regulation of telomerase, Nucleic Acids Res. 30 (2002) 839-865.
19. D. Sen, W. Gilbert, Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its applications for meiosis, Nature 334 (1988) 364-366.
20. A.M. Zahler, J.R. Williamson, T.R. Cech, D.M. Prescott, Inhibition of telomerase by G-quartet DNA structures, Nature 350 (1991) 718-720.
21. P.J. Perry, T.C. Jenkins, DNA tetraplex binding drugs: Structure-selective targeting is critical for antitumor telomerase inhibition, Mini Rev. Med. Chem. 1 (2001) 31-41.
22. K. Gehring, J.L. Leroy, M. Guéron, A tetrameric structure with protonated cytosine-cytosine base pairs, Nature 363 (1993) 561-565.
23. J.L. Leroy, K. Gehring, A. Kettani, M. Guéron, Acid multimers of oligodeoxycytidine strands: Stoichiometry, base pair characterization and proton exchange properties, Biochemistry 32 (1993) 6019-6031.
24. K. Cimanga, T. De Bruyne, A. Lasure, B. Van Poel, L. Pieters, M. Claeys, D. Vanden-Berghe, K. Kambu, L. Tona, A.J. Vlietinck, In vitro biological activities of alkaloids from Cryptolepis sanguinolenta, Planta Med. 62 (1996) 22-27.
25. T.H. Jonckers, S. Van Miert, K. Cimanga, C. Bailly, P. Colson, M.C. De Pauw-Gillet, H. Van Den Heuvel, M. Claeys, F. Lemiere, E.L. Esmans, J. Rozenski, L. Quirijnen, L. Maes, R. Dommisse, G.L. Lemiere, A. Vlietinck, L. Pieters, Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives, J. Med. Chem. 45 (2002) 3497-3508.
26. J. Ren, J.B. Chaires, Sequence and structural selectivity of nucleic acid binding ligands, Biochemistry 38 (1999) 16067-16075.
27. P. Alberti, P. Schmitt, C.H. Nguyen, C. Rivalle, M.D.S.G. Hoarau, J.L. Mergny, Benzoindoloquinolines interact with DNA tetraplexes and inhibit telomerase, Bioorg. Med. Chem. Lett. 12 (2002) 1071-1074.
28. P. Alberti, M. Hoarau, L. Guittat, M. Takasugi, P.B. Arimondo, L. Lacroix, M. Mills, M.P. Teulade-Fichou, J.P. Vigneron, J.M. Lehn, P. Mailliet, J.L. Mergny, in: C. Bailly, M. Demeunynck, D. Wilson (Eds.), Small Molecule DNA and RNA Binders: From Synthesis to Nucleic Acid Complexes, Wiley VCH, 2002, pp. 315-336.
29. J.S. Ren, C. Bailly, J.B. Chaires, NB-506, an indolocarbazole topoisomerase I inhibitor, binds preferentially to triplex DNA, FEBS Lett. 470 (2000) 355-359.
30. J.S. Ren, J.B. Chaires, Preferential binding of 3,3′-diethyloxadicarbocyanine to triplex DNA, J. Am. Chem. Soc. 122 (2000) 424-425.
31. P. Alberti, J. Ren, M.P. Teulade-Fichou, L. Guittat, J.F. Riou, J. Chaires, C. Helene, J.P. Vigneron, J.M. Lehn, J.L. Mergny, Interaction of an acridine dimer with DNA quadruplex structures, J. Biomol. Struct. Dyn. 19 (2001) 505-513.
32. A.T. Phan, J.L. Leroy, Intramolecular i-motif structures of telomeric DNA, J. Biomol. Struct. Dyn. Sp. Iss. S2 (2002) 245-252.
33. F. Rosu, V. Gabelica, C. Houssier, P. Colson, E. De Pauw, Triplex and quadruplex DNA structures studied by electrospray mass spectrometry, Rapid Commun. Mass Spectrom. 16 (2002) 1729-1736.
34. F. Rosu, V. Gabelica, C. Houssier, E. De Pauw, Determination of affinity, stoichiometry and sequence selectivity of minor groove binder complexes with double-stranded oligodeoxynucleotides by electrospray ionisation mass spectrometry, Nucleic Acids Res. 30 (2002) e82.
35. J.L. Mergny, J.C. Maurizot, Fluorescence resonance energy transfer as a probe for G-quartet formation by a telomeric repeat, Chem. Bio. Chem. 2 (2001) 124-132.
36. J.L. Mergny, A.T. Phan, L. Lacroix, Following G-quartet formation by UV-spectroscopy, FEBS Lett. 435 (1998) 74-78.
37. J.F. Riou, L. Guittat, P. Mailliet, A. Laoui, E. Renou, O. Petitgenet, F. Megnin-Chanet, C. Helene, J.L. Mergny, Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands, Proc. Natl. Acad. Sci. USA 99 (2002) 2672-2677.
38. S.A. Hofstadler, R.H. Griffey, Analysis of noncovalent complexes of DNA and RNA by mass spectrometry, Chem. Rev. 101 (2001) 377-390.
39. J. Beck, M.L. Colgrave, S.F. Ralph, M.M. Sheil, Electrospray ionization mass spectrometry of oligonucleotide complexes with drugs, metals, and proteins, Mass Spectrom. Rev. 20 (2001) 61-87.
40. V. Gabelica, E. De Pauw, F. Rosu, Interaction between antitumor drugs and double-stranded DNA studied by electrospray ionization mass spectrometry, J. Mass Spectrom. 32 (1999) 1328-1337.
41. K.X. Wan, T. Shibue, M.L. Gross, Non-covalent complexes between DNA-binding drugs and double-stranded oligodeoxynucleotides: A study by electrospray ionization mass spectrometry, J. Am. Chem. Soc. 122 (2000) 300-307.
42. Y. Wang, D.J. Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-Tetraplex, Structure 1 (1993) 263-282.
43. G.N. Parkinson, M.P.H. Lee, S. Neidle, Crystal structure of parallel quadruplexes from human telomeric DNA, Nature 417 (2002) 876-880.
44. J.L. Mergny, L. Lacroix, M.P. Teulade-Fichou, C. Hounsou, L. Guittat, M. Hoarau, P.B. Arimondo, J.P. Vigneron, J.M. Lehn, J.F. Riou, T. Garestier, C. Helene, Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay, Proc. Natl. Acad. Sci. USA 98 (2001) 3062-3067.
45. D. Sun, B. Thompson, B.E. Cathers, M. Salazar, S.M. Kerwin, J.O. Trent, T.C. Jenkins, S. Neidle, L.H. Hurley, Inhibition of human telomerase by a G-quadruplex-interactive compound, J. Med. Chem. 40 (1997) 2113-2116.
46. S.M. Kerwin, G-quadruplex DNA as a target for drug design, Curr. Pharm. Des. 6 (2000) 441-478.
47. V. Caprio, B. Guyen, Y. Opoku-Boahen, J. Mann, S.M. Gowan, L.M. Kelland, M.A. Read, S. Neidle, A novel inhibitor of human telomerase derived from 10H-indolo[3-2-b]quinoline, Bioorg. Med. Chem. Lett. 10 (2000) 2063-2066.
48. M. Read, R.J. Harrison, B. Romagnoli, F.A. Tanious, S.H. Gowan, A.P. Reszka, W.D. Wilson, L.R. Kelland, S. Neidle, Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors, Proc. Natl. Acad. Sci. USA 98 (2001) 4844-4849.
49. M.Y. Kim, H. Vankayalapati, K. Shin-Ya, K. Wierzba, L.H. Hurley, Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular G-quadruplex, J. Am. Chem. Soc. 124 (2002) 2098-2099.
50. K. Shin-Ya, K. Wierzba, K. Matsuo, T. Ohtani, Y. Yamada, K. Furihata, Y. Hayakawa, H. Seto, Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus, J. Am. Chem. Soc. 123 (2001) 1262-1263.
51. R. Cao, C.F. Venezia, B.A. Armitage, Investigation of DNA binding modes for a symmetrical cyanine dye trication: Effect of DNA sequence and structure, J. Biomol. Struct. Dyn. 18 (2001) 844-856.
52. D.P. Arya, R.L. Coffee Jr, I. Charles, Neomycin-induced hybrid triplex formation, J. Am. Chem. Soc. 123 (2001) 11093-11094.
53. D.S. Pilch, M.T. Martin, C.H. Nguyen, J.S. Sun, E. Bisagni, T. Garestier, C. Hélène, Self-association and DNA-binding properties of two triple helix-specific ligands: Comparison of a benzo[e]- and a benzo[g-]pyridoindole, J. Am. Chem. Soc. 115 (1993) 9942-9951.
54. C.H. Nguyen, E. Fan, J.F. Riou, M.C. Bissery, P. Vrignaud, F. Lavelle, E. Bisagni, Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b]quinoxalines: A new class of antineoplastic agents, Anticancer Drug Des. 10 (1995) 277-297.
55. B. Gatto, M.M. Sanders, C. Yu, H.Y. Wu, D. Makhey, E.J. LaVoie, L.F. Liu, Identification of topoisomerase I as the cytotoxic target of the protoberberine alkaloid coralyne, Cancer Res. 56 (1996) 2795-2800.